Archived PandoMedia · Undo
iNeuroskill
Surrogate Biomarker for Parkinson's Disease
3e1efca063e968bfe619e09dff7863a3-original 859f47b345850d86dd4743957e83f76e-original 19ab8a69d06db2c1c027ee5f44fd6cf4-original
859f47b345850d86dd4743957e83f76e-original
3e1efca063e968bfe619e09dff7863a3-thumb 859f47b345850d86dd4743957e83f76e-thumb 19ab8a69d06db2c1c027ee5f44fd6cf4-thumb
Product

Neuroskill is a device that measures impairment in fine motor control by recording and analyzing the patient's handwriting dynamics in real time. With the help of the Neuroskill device, physicians can potentially diagnose Parkinon's Disease as well as monitor progress of pharmacological treatment.

Founders
  • Nopic
    Cancel
  • Alexander Landau
    Co-Founder of iNeuroskill. Past experience: Principal Investigator in Russian Space program. Manager of Avionics at Israel Aircraft Industries.
  • Danny Landau
    VP Operations & Business Dev at iNeuroskill as well as VP at Verifax Biometrics. Bachelors in Mathematics & Psychology. MBA from Columbia University.
Previous Investors
  • Nopic
    Cancel
  • Nopic
    National Institute of Health (NIH)
    Unconfirmed